Immunogenicity of BNT162b2 COVID-19 vaccine in New Zealand adults. Priddy FH, Williams M, Carson S, Lavender B, et al. Vaccine 2022 Jul 12. pii: S0264-410X(22)00885.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Priddy FH, Williams M, Carson S, Lavender B, et al. Immunogenicity of BNT162b2 COVID-19 vaccine in New Zealand adults. Vaccine 2022 Jul 12. pii: S0264-410X(22)00885.
PMID: 35868948